Atlas Trials

Study Comparing Standard Dose and Reduced Dose Tacrolimus With Sirolimus in Renal Transplant Patients

Clinical trial NCT00519116 · COMPLETED

Trial details

NCT number
NCT00519116
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Kidney Transplantation
Start date
2000-10-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.